Literature DB >> 20570234

Similar effects of selective laser trabeculoplasty and prostaglandin analogs on the permeability of cultured Schlemm canal cells.

Jorge A Alvarado1, Rumiko Iguchi, Juan Martinez, Sheetal Trivedi, Amde Selassie Shifera.   

Abstract

PURPOSE: To evaluate whether selective laser trabeculoplasty and prostaglandin analogs regulate the permeability of cultured human Schlemm canal cells by inducing intercellular junction disassembly.
DESIGN: Laboratory investigation.
METHODS: Intercellular junctions were made visible in living cells by making them fluoresce after transfection with a plasmid expressing the zonula occludens 1 protein tagged with green fluorescent protein. Schlemm canal cells were treated by direct laser irradiation; by exposure to media conditioned by either lasered Schlemm canal cells or trabecular meshwork cells; by exposure to the prostaglandin analogs latanoprost, bimatoprost, and travoprost; or by the addition of the nonprostaglandin agents brimonidine, timolol, and dorzolamide. Junction disassembly was monitored using fluorescence microscopy, and permeability alterations were measured as changes in conductivity using flow meters.
RESULTS: The direct laser irradiation of Schlemm canal cells caused a 3-fold increase in conductivity. Exposure of the cells to media conditioned by lasered Schlemm canal cells or trabecular meshwork cells induced junction disassembly and a 2- to 4-fold increase in conductivity. Exposure to prostaglandin analogs also induced junction disassembly and a 4- to 16-fold increase in conductivity, whereas the 3 nonprostaglandin agents tested were ineffective in both regards.
CONCLUSIONS: Exposure to factors secreted by lasered Schlemm canal cells and lasered trabecular meshwork cells and the application of prostaglandin analogs induced junction disassembly while increasing the permeability of Schlemm canal cells. These findings support our hypothesis that selective laser trabeculoplasty and prostaglandin analogs share a common mechanism that likely mediates their pressure-lowering effects. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20570234     DOI: 10.1016/j.ajo.2010.03.012

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  18 in total

1.  Profiling of Cytokines Secreted by Conventional Aqueous Outflow Pathway Endothelial Cells Activated In Vitro and Ex Vivo With Laser Irradiation.

Authors:  Jorge A Alvarado; Phuonglan Chau; Jianfeng Wu; Richard Juster; Amde Selassie Shifera; Michael Geske
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-11       Impact factor: 4.799

Review 2.  Selective laser trabeculoplasty: past, present, and future.

Authors:  A Garg; G Gazzard
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

3.  Selective laser trabeculoplasty (SLT): 1-year results in early and advanced open angle glaucoma.

Authors:  Torsten Schlote; Myron Kynigopoulos
Journal:  Int Ophthalmol       Date:  2015-05-06       Impact factor: 2.031

4.  Selective laser trabeculoplasty.

Authors:  Jing-Ming Shi; Song-Bai Jia
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

5.  Imaging the effects of prostaglandin analogues on cultured trabecular meshwork cells by coherent anti-stokes Raman scattering.

Authors:  Tim C Lei; Omid Masihzadeh; Malik Y Kahook; David A Ammar
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-03       Impact factor: 4.799

6.  [Effectiveness of selective laser trabeculoplasty in patients with insufficient control of intraocular pressure despite maximum tolerated medical therapy].

Authors:  C Hirn; S A Zweifel; M Töteberg-Harms; J Funk
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

Review 7.  Selective laser trabeculoplasty is safe and effective in patients previously treated with prostaglandin analogs: An evidence-based review.

Authors:  Raul E Ruiz-Lozano; Jimena Alamillo-Velazquez; Gustavo Ortiz-Morales; Lucas A Garza-Garza; Manuel E Quiroga-Garza; Carlos Alvarez-Guzman; Alejandro Rodriguez-Garcia
Journal:  Int Ophthalmol       Date:  2022-08-13       Impact factor: 2.029

8.  Low-energy Selective Laser Trabeculoplasty Repeated Annually: Rationale for the COAST Trial.

Authors:  Tony Realini; Gus Gazzard; Mark Latina; Michael Kass
Journal:  J Glaucoma       Date:  2021-07-01       Impact factor: 2.290

Review 9.  Selective laser trabeculoplasty: current perspectives.

Authors:  Kate E Leahy; Andrew Jr White
Journal:  Clin Ophthalmol       Date:  2015-05-11

10.  Baseline Factors Predictive of SLT Response: A Prospective Study.

Authors:  Robin Bruen; Mark R Lesk; Paul Harasymowycz
Journal:  J Ophthalmol       Date:  2012-07-31       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.